The effect of amphetamine sensitization on mouse immunoreactivity.
Recent studies indicate a role of the immune system in the behavioral effects of amphetamine in rodents. In the present study we attempted to find a connection between the behavioral changes induced by repeated, intermittent administration of amphetamine and some immunological consequences of sensitization to amphetamine in mice. Male Albino Swiss mice were treated repeatedly (for 5 days) with amphetamine (1 mg/kg, i.p.). On day 9, they received a challenge dose of amphetamine (1 mg/kg). Acute administration of amphetamine increased their locomotor activity by ca. 40%. In animals treated repeatedly with amphetamine, the challenge dose of the psychostimulant induced behavioral sensitization, i.e. the higher locomotor activation as compared with that after its first administration to mice. Immune functions were evaluated by the ability of splenocytes to proliferate and to produce cytokines such as interferon gamma (IFN-gamma), interleukin (IL)-4 and IL-10. Acute amphetamine administration significantly decreased, by ca. 30% and 25%, the proliferation of splenocytes in response to an optimal and a suboptimal dose of concanavalin A (Con A), respectively, and increased their ability to produce IL-4. Chronic intermittent treatment with amphetamine significantly decreased, by ca. 65% and 50%, the proliferative response of T cells to an optimal and a suboptimal dose of Con A, respectively, and diminished by 20% the metabolic activity of splenocytes. The above data showed that both acute and chronic amphetamine administration diminished some aspects of the cell-mediated immunity; nevertheless, immunosuppression was particularly evident in amphetamine-sensitized mice. Our findings seem to indicate possible importance of monitoring and correcting immune changes in the therapy of amphetamine addiction.
Kubera
M
M
Department of Endocrinology, Institute of Pharmacology, Polish Academy of Sciences, Kraków. Kubera@if-pan.krakow.pl
Filip
M
M
Basta-Kaim
A
A
Nowak
E
E
Budziszewska
B
B
Tetich
M
M
Holan
V
V
Korzeniak
B
B
Przegaliński
E
E
D000661:Amphetamine / Q000276:immunology*; D000818:Animals; D001522:Behavior, Animal / Q000502:physiology; D002455:Cell Division / Q000502:physiology; D007107:Immune System / Q000502:physiology*; D007114:Immunization; D008214:Lymphocytes / Q000378:metabolism; D008222:Lymphokines / Q000096:biosynthesis; D008297:Male; D051379:Mice; D009929:Organ Size; D013154:Spleen / Q000033:anatomy & histology / Q000166:cytology / Q000378:metabolism; D013950:Thymus Gland / Q000033:anatomy & histology
D008222:Lymphokines; D000661:Amphetamine